Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Anatara Lifesciences.
RELATED STOCKHEAD STORIES
Health & Biotech
Factor Therapeutics may finally have found its future — in veterinary imaging
Health & Biotech
ASX investors super happy that FDA may approve first new contraceptive pill in 11 years
Health & Biotech
When your guts have gone nuts, who do you call? These ASX stocks are fighting gastrointestinal disease
Stockhead TV
VIDEO: 90 Seconds With… Steven Lydeamore, Anatara Lifesciences
Health & Biotech
Check up: Cashing in on deals done long ago
News
Trading Places: Here are this week’s substantial holder movements
Health & Biotech
Health: Alterity gets orphan status for its MSA drug
Health & Biotech
Health: Gut treatment progress gives Anatara a 24pc boost
Health & Biotech
Our pets are living longer, happier lives and it’s a $US125bn market; here are the small cap contenders
Health & Biotech
Here’s what policymakers must do keep ASX life science companies from going overseas
Health & Biotech
Health: Admedus shares fly 40pc on first trading day in six months
News
Top 10 at 10: These ASX stocks are in the lead today
News
Kick Back: The 10 biggest stories you might have missed on Stockhead this week
News
This small cap biotech proves it is possible to have more women than men on a board
Health & Biotech
IBS sufferers – Anatara Lifesciences reckons it has a breakthrough formula to help
Health & Biotech
Is Anatara good value after 40pc share price drop?
News
